{"id":"W2085835360","doi":"10.1007/s10549-014-3259-1","title":"Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Clinical Oncology Group; Saint John Regional Hospital; McMaster University; Queen's University; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute; Plexxikon; Susan G. Komen; Bristol-Myers Squibb; Amgen; Pfizer; Sanofi; Cancer Research Institute; BC Cancer Agency; Susan G. Komen for the Cure","keywords":"Epirubicin; Medicine; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Proportional hazards model; Chemotherapy; Hazard ratio; Paclitaxel; Multivariate analysis; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959018,0.0005636238,0.0009646933,0.0002254589,0.0003560932,0.001083398,0.0006684927,0.0005792495,0.002335327],"category_scores_gemma":[0.002865808,0.0002282628,0.000505793,0.0005249677,0.0004201252,0.0006332597,0.0004135802,0.001253459,0.0004956269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008095402,"about_ca_system_score_gemma":0.001079871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001434393,"about_ca_topic_score_gemma":0.005305749,"domain_scores_codex":[0.9991391,0.0005633452,0.00003041737,0.00008579356,0.00007099497,0.0001103451],"domain_scores_gemma":[0.9988155,0.000375191,0.0002686944,0.0001557732,0.0000719196,0.0003128407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4890948,0.003444353,0.2727921,0.0005239245,0.002719965,0.0002244153,0.0002968243,0.006691131,0.01385646,0.001850154,0.01880101,0.1897048],"study_design_scores_gemma":[0.07511107,0.07213132,0.8143307,0.0002644507,0.003714744,0.0005887992,0.0002352058,0.01058494,0.004005223,0.003209176,0.0157151,0.000109181],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912075,0.002329034,0.0001648628,0.0006395658,0.00005285017,0.0001820298,0.001222064,0.00002530957,0.004176768],"genre_scores_gemma":[0.9944443,0.0007293936,0.0003094562,0.0003669675,0.00008558651,0.0002274413,0.002436632,0.00001192127,0.001388323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002335327,"threshold_uncertainty_score":0.01036036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02964056418049475,"score_gpt":0.3376639210899575,"score_spread":0.3080233569094627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}